Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Invitae Corp
(NY:
NVTA
)
N/A
UNCHANGED
Last Price
Updated: 7:00 PM EST, Feb 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Invitae Corp
< Previous
1
2
3
4
5
6
7
8
9
Next >
Invitae's Earnings: A Preview
November 05, 2021
Invitae (NYSE:NVTA) is set to give its latest quarterly earnings report on Monday, 2021-11-08. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
3 Cathie Wood Stocks to Watch This Earnings Season
October 26, 2021
All eyes will be watching these ARK Invest holdings to see if they're working out as hoped.
Via
The Motley Fool
Cathie Wood Goes Bargain Shopping: 3 Sinking Stocks She Keeps Buying
September 20, 2021
The CEO of ARK Invest is averaging down on these compelling life-science stocks.
Via
The Motley Fool
Cathie Wood Goes Dumpster Diving: 3 Beaten Down Stocks She Just Bought
September 09, 2021
All of these stocks are more than 40% below their peaks, but at least one important investor thinks they can recover.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 08, 2021
Gainers Cardiff Oncology (NASDAQ:
Via
Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
August 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...
Via
Benzinga
Understanding Invitae's Unusual Options Activity
August 03, 2021
On Tuesday, shares of Invitae (NYSE:NVTA) saw unusual optio...
Via
Benzinga
Invitae Strengthens Health Data Platform With Ciitizen Acquisition
September 07, 2021
Invitae Corp (NYSE: NVTA) has agreed to acquire consumer health technology company Ciitizen for $325 million in a bid to make it easier for patients to collect...
Via
Benzinga
Return on Capital Employed Overview: Invitae
August 20, 2021
After pulling data from Benzinga Pro it seems like during Q2, Invitae (NYSE:NVTA) earned $128.61 million, a 214.46% increase from the preceding quarter. Invitae also posted a...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
August 16, 2021
On Monday morning, 207 companies hit new 52-week lows. Intriguing Points: The largest company in terms of market cap to set a new 52-week low was Koninklijke Philips (NYSE...
Via
Benzinga
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
August 09, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
20 Stocks Moving in Monday's Pre-Market Session
August 09, 2021
Gainers Windtree Therapeutics, Inc. (NASDAQ: WINT) shares rose 55.8% to $2.82 in pre-market trading after dropping over 10% on Friday. The company recently reported a wider loss...
Via
Benzinga
Why Did Invitae Stock Fall 17% in July?
August 06, 2021
This genetic testing innovator slumped along with other genomics stocks last month.
Via
The Motley Fool
Why Invitae Stock Is Climbing Today
August 04, 2021
Accelerating growth is giving investors more confidence in the genetic testing company's long-term prospects.
Via
The Motley Fool
88 Biggest Movers From Yesterday
August 05, 2021
Gainers BeyondSpring Inc. (NASDAQ: BYSI) shares climbed 176% to close at $26.58 on Wednesday in reaction to topline data from DUBLIN-3 Phase 3 trial evaluating plinabulin in...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2021
August 04, 2021
Upgrades For Meritage Homes Corp (NYSE:
Via
Benzinga
Invitae Stock Jumps As Higher Test Volume More Than Doubles Q2 Topline, Raises FY21 Sales Outlook
August 04, 2021
Invitae Corporation (NYSE: NVTA), after the close of the market on Tuesday, reported its second-quarter revenues of $116.3 million, +152% Y/Y, exceeding the consensus...
Via
Benzinga
Invitae (NVTA) Q2 2021 Earnings Call Transcript
August 04, 2021
NVTA earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
30 Stocks Moving in Wednesday's Pre-Market Session
August 04, 2021
Gainers Alterity Therapeutics Limited (NASDAQ: ATHE) shares rose 34.8% to $1.84 in pre-market trading after gaining around 3% on Tuesday. Wheeler Real Estate Investment Trust,...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 03, 2021
Gainers Cerus (NASDAQ:CERS) shares incre...
Via
Benzinga
14 Stocks Moving In Tuesday's After-Hours Session
August 03, 2021
RingCentral (NYSE: RNG) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and issued Q3 and FY21 EPS and sales guidance above...
Via
Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Earnings Scheduled For August 3, 2021
August 03, 2021
Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to...
Via
Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
Pacific Biosciences To Buy DNA Sequencing Firm For Up To $800M, Announces $300M Capital Raise For Deal Funding
July 20, 2021
Pacific Biosciences of California Inc (NASDAQ: PACB) has agreed to acquire Omniome, a San Diego-based company developing a short-read sequencing platform. Under...
Via
Benzinga
Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week
July 16, 2021
The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news.
Via
The Motley Fool
3 Things About Invitae That Smart Investors Should Know
July 13, 2021
Could Invitae become the first $1 trillion market cap healthcare company?
Via
The Motley Fool
Analyzing Invitae's Unusual Options Activity
June 17, 2021
On Thursday, shares of Invitae (NYSE:NVTA) saw unusual options activity. After the option alert, the stock price moved up to $31.08. Sentiment: BULLISH Option Type: SWEEP Trade...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021
June 15, 2021
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.